An open multicentre pilot study examining the safety, efficacy and tolerability of fast titrated (800 mg/day by day 4) quetiapine in the treatment of schizophrenia/schizoaffective disorder

By Peuskens J.   Devoitille J. M.   Kusters J.   Vandenhoven G.  

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 4, 2008-01 ,pp. : 261-267

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Combined clozapine-lithium treatment for schizophrenia and schizoaffective disorder

By Moldavsky M.   Stein D.   Benatov R.   Sirota P.   Elizur A.   Matzner Y.   Weizman A.  

European Psychiatry, Vol. 13, Iss. 2, 1998-01 ,pp. : 104-106

Elsevier

Access to resources Recommend Favorite

Smooth pursuit eye movements of patients with schizophrenia and affective disorder during clinical treatment

By Flechtner Klaus-Malte   Steinacher Bruno   Sauer Robert   Mackert Arthur  

European Archives of Psychiatry and Clinical Neuroscience, Vol. 252, Iss. 2, 2002-04 ,pp. : 49-53

Springer Publishing Company

Access to resources Recommend Favorite

An Open Trial of Olanzapine in the Treatment of Patients with Psychotic Depression

By Nelson E.B.  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 13, Iss. 3, 2001-09 ,pp. : 147-151

Springer Publishing Company

Access to resources Recommend Favorite

Open-label olanzapine in obsessive-compulsive disorder refractory to antidepressant treatment

By Crocq M.A.   Leclercq P.   Guillon M.S.   Bailey P.E.  

European Psychiatry, Vol. 17, Iss. 5, 2002-09 ,pp. : 296-297

Elsevier

Access to resources Recommend Favorite